Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke — Catch-up-ESUS  

Embolic Stroke of Undetermined Source Clinical Trial

Official title: Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke (ESUS = Embolic Stroke of Undetermined Source)

Status Recruiting

Clinical Trial Summary

Up to know, there is no clear diagnostic and therapeutic pathway for patients with embolic stroke of undetermined source (ESUS). This prospective registry study, which follows up adult ESUS patients for 36 months, is intended to provide important data for the detection of an individual approach in ESUS patients based on a structured diagnostic and therapeutic pathway.

Clinical Trial Description

The open-label, academic, prospective, monocentric, observational registry-study (Catch-up-ESUS registry study) started in 01/2018. All ESUS-patients (≥18 years) treated in our hospital are included and will be followed up for three years. Depending on age (< 60 years or ≥ 60 years), the patients are processed according to a standardized treatment algorithm designed interdisciplinary by neurologists and cardiologists. An insertable cardiac monitor (ICM) is implanted in all of them by default. Patients < 60 years without evidence of atrial fibrillation and co-existing PFO are planned for PFO closure within 6 months after stroke. ;

Related Conditions & MeSH terms

• Embolic Stroke of Undetermined Source
• Stroke

• NCT number: NCT03820375
• Study type: Observational [Patient Registry]
• Source: Ludwig-Maximilians - University of Munich
• Contact: Lars Kellert, MD
• Phone: 0049 (0) 89 4400 73962
• Email: Lars.Kellert@med.uni-muenchen.de
• Status: Recruiting
• Start date: January 1, 2018
• Completion date: January 1, 2026